notv stock — NOTV (Inotiv, Inc.) Overview

NOTV (Inotiv, Inc.) — Overview

This guide focuses on notv stock (Inotiv, Inc.), the Nasdaq-listed ticker for a U.S. pharmaceutical development and research-models company. Inotiv provides nonclinical and analytical drug discovery and development services, and produces research animals and related products. Readers will get a company profile, business segment breakdown, corporate milestones, stock information and metrics, analyst and market-sentiment context, recent news highlights, risks, governance overview, investor-relations pointers, and practical guidance on how to trade notv stock. The content is neutral and fact-oriented; always confirm live market data and filings before making decisions.

Company Profile

Inotiv, Inc. (ticker: NOTV) is a U.S.-based company offering nonclinical drug discovery and development services alongside research models and consumables. The company’s stated purpose is to support pharmaceutical, biotechnology and academic clients with preclinical research, toxicology, and model organism resources that facilitate development of therapies and diagnostics.

• Founded: 1974 (original corporate lineage in laboratory services and bioanalytical work).
• Headquarters: West Lafayette, Indiana, United States.
• Primary sectors: Diagnostics & Research; Healthcare.

As a provider of contract research services and research animals/products, Inotiv occupies a specialized niche linking laboratory operations, regulatory toxicology, and supply of in vivo research models.

Business Segments

Inotiv operates primarily through two core business segments that reflect the company’s service and product mix:

• Discovery and Safety Assessment (DSA): This segment provides nonclinical drug discovery and development services. It includes GLP (Good Laboratory Practice) and non-GLP studies, pharmacology, ADME (absorption, distribution, metabolism, excretion) characterization, exploratory toxicology, and analytical services that support early- through mid-stage drug development.

• Research Models and Services (RMS): This segment produces and supplies research animals (e.g., rodents), specialized diets, bedding, and related biological products and services. RMS supports academic laboratories, contract research organizations (CROs), and industry researchers who rely on standardized, high-quality animal models and consumables.

These segments together create a vertically complementary offering: RMS supplies research materials used in DSA-style studies, while DSA provides laboratory services that rely on sourced models and consumables.

Corporate History and Milestones

Inotiv’s corporate lineage traces back to laboratory services firms formed in the 1970s. Important historical and strategic points include:

• Founding and early history: The corporate roots date to 1974, with companies focused on bioanalytical services and laboratory testing.

• Name and brand evolution: The company formerly operated under names such as Bioanalytical Systems. In 2021 the company adopted the Inotiv name to reflect a consolidated brand and expanded service offering across research models and nonclinical services.

• Strategic shifts: Over time, leadership emphasized integrating research-model production with nonclinical services to offer broader, end-to-end preclinical support. Public filings and press releases documented investments in laboratory capacity, acquisitions or partnerships aimed at broadening service lines, and platform adoptions for study tracking and analytics.

• Partnerships and platform adoption: Company releases and industry coverage have cited collaborations with pharmaceutical and biotech customers, adoption of digital study-management platforms, and investments intended to increase throughput and regulatory compliance capabilities.

Note: As with many companies in the CRO and research-supplies space, specific partnership terms, acquisition dates, and one-off strategic events are documented in SEC filings and company press releases. Investors and researchers should consult those primary sources for exact timelines and contractual details.

Stock Information

notv stock trades on the Nasdaq exchange under the ticker NOTV. The company is commonly classified as a micro-cap or small-cap issuer depending on market conditions, and it typically exhibits the liquidity and volatility characteristics associated with smaller public companies.

Key trading considerations for notv stock:

• Exchange and ticker: Nasdaq — NOTV.
• Market-cap classification: Historically in the micro-cap to lower small-cap range; market-cap bands for such companies commonly span tens of millions to several hundred million USD depending on price movement.
• Liquidity: Trading volume can be modest and variable, which can result in wider bid-ask spreads and larger intraday price changes compared with larger-cap equities.

As of 2026-01-28, according to major financial data providers such as Nasdaq and Yahoo Finance, live quote pages for NOTV are the authoritative sources for up-to-date price, market cap, 52-week range and average volume. Because these metrics change continuously, please consult your brokerage or data provider for current figures before trading notv stock.

Key Market Metrics

Investors typically track a standard set of market metrics for notv stock and similar issuers. These are commonly published by financial data providers and appear in company profiles:

• Last traded price: The most recent execution price for the ticker; changes intraday.
• 52-week high / 52-week low: The highest and lowest trade prices over the trailing 52 weeks; useful for volatility and range context.
• Market capitalization: Share price multiplied by shares outstanding; indicates company market size and risk profile.
• P/E ratio (Price/Earnings): If the company reports positive earnings, the P/E can appear; many smaller or growing companies report negative earnings and therefore have no meaningful P/E.
• EPS (TTM): Earnings per share on a trailing-12-month basis; used in conjunction with P/E.
• Price/Sales and Price/Book ratios: Valuation measures useful when earnings are negative or to compare to peers.
• Average daily volume: Short-term or 3-month average of daily shares traded; informs liquidity.
• Beta: A historical measure of price correlation with the broader market; micro-cap stocks often show higher beta values but specific beta varies by period and source.

Note: Each provider (Morningstar, Yahoo Finance, Reuters/LSEG, Nasdaq) may show slightly different figures due to data timing, share count estimates, and adjustment methodologies. Historical snapshots from these providers are useful, but live data remains the definitive quote.

Historical Price Performance

notv stock has displayed volatility typical of micro-cap and sector-specific stocks. Price performance drivers often include: company earnings releases, contract announcements, acquisition or divestiture activity, sector news (e.g., regulatory trends impacting nonclinical testing), and broader market sentiment.

• Short-term trends: Investors often see sharp intraday or weekly moves around earnings, material agreements, or regulatory announcements.
• Longer-term moves: Over multi-year periods, price trends have reflected business reorganizations, rebranding (such as the 2021 change to Inotiv), revenue trajectory, and capital-raising events.

As of 2026-01-28, for a current view of 52-week ranges and historical charts, consult established market-data pages (e.g., Nasdaq, Yahoo Finance, Reuters). Those pages provide interactive charts and downloadable history for notv stock and are the best source for understanding recent runs or declines.

Financial Results and Valuation

Inotiv’s financial profile includes revenue driven by DSA and RMS segment activity, operating costs related to laboratory operations and animal production, and balance-sheet items that reflect working capital, cash, and debt levels. Key financial items commonly summarized by analysts include:

• Revenue: Generated from both service contracts (DSA) and product sales (RMS). Revenue trends depend on customer demand from pharma/biotech clients and institutional buyers.
• Profitability: Smaller CROs and research-model firms often experience periods of operating losses due to capital investments, integration costs after acquisitions, or cyclic demand patterns. Net income and EPS (TTM) are central metrics to watch in quarterly reports.
• Balance sheet highlights: Cash and equivalents, short-term debt, long-term debt and lease obligations, and working capital changes. These factors influence liquidity and ability to fund expansion or absorb cyclic downturns.
• Valuation ratios: Price/Sales and Price/Book are commonly used when P/E is not meaningful. Analysts may also apply discounted cash flow (DCF) methods or peer multiples, with adjustment for business mix and growth prospects.

Analyst fair-value commentary and third-party quantitative models (e.g., Morningstar) are occasionally available for notv stock, but coverage may be limited due to the company’s market cap and niche sector. Where available, analyst reports will cite revenue forecasts, margin expectations, and valuation recommendations. Always check the publication date of such commentary—financial forecasts and fair-value estimates change as new results and guidance are issued.

Analyst Coverage and Market Sentiment

Coverage for notv stock can be sparse relative to large-cap names. When coverage exists, it is typically published by small research boutiques or regional brokers and summarized by data aggregators.

• Analyst ratings and price targets: These may be reported on aggregator pages (e.g., Yahoo Finance, Nasdaq research summaries). Coverage may include categorizations such as Buy/Hold/Sell and one- or two-year price target ranges.
• Retail sentiment: Social platforms and stock community feeds often discuss notv stock in the context of small-cap speculation, sector interest in CROs, or reactions to corporate announcements. Retail sentiment indicators are available on community-driven sites and can influence short-term trading dynamics.

As of 2026-01-28, consult data providers and news aggregators for the latest analyst notes and consensus where present. Remember that analyst coverage and consensus can change rapidly and that coverage intensity for micro-cap names is often limited.

Recent News, Partnerships and Regulatory Matters

Investors in notv stock pay attention to company press releases, SEC filings, and reputable news outlets for developments such as:

• Strategic partnerships and customer contracts: Periodic press releases highlight work-for-hire agreements with pharmaceutical or biotech firms, multi-year supply arrangements for research animals, or collaborations for specialized toxicology services.
• Earnings releases and guidance updates: Quarterly results and management commentary affect expectations for revenue growth and margin recovery.
• Regulatory and listing matters: As with many small-cap public companies, observers monitor SEC filings and Nasdaq notices for any reporting delinquencies or minimum-bid-price compliance matters. These items can influence investor perception and share liquidity.

As of 2026-01-28, readers should check the company’s investor-relations press release archive and SEC EDGAR filings for the most recent announcements and regulatory communications. Industry news platforms and trusted financial-data sites report contemporaneous summaries and should be used to verify the timing and substance of any material events.

Risks and Considerations

Holding or trading notv stock entails a set of risk factors that are common to companies in the contract research and research-models sector, as well as some company-specific exposures:

• Sector-specific risks: R&D cycles and client spending in pharma/biotech are cyclical. Changes in drug-development pipelines, regulatory priorities, or public funding can affect demand for preclinical services and models.
• Regulatory exposure: Nonclinical services are subject to GLP and other regulatory standards. Failures in compliance can cause reputational and financial harm.
• Financial risks: Smaller companies may report negative earnings, operate with limited free cash flow, and rely on capital markets for funding. High leverage or liquidity constraints increase vulnerability.
• Operational risks: Production of research animals and consumables requires strict quality control, biosecurity, and supply-chain management. Disruptions (disease outbreaks in animal colonies, supply interruptions for feed or supplies) can materialize.
• Liquidity and volatility: notv stock has micro-cap characteristics; volume can be limited and price moves may be amplified by low float events or concentration of holders.
• Legal and compliance risks: Contract disputes, regulatory investigations, or environmental and animal-welfare compliance issues can have financial and reputational consequences.

Investors should review the company’s Form 10-K and Form 10-Q filings for an authoritative discussion of risk factors and to assess how management is addressing each exposure.

Corporate Governance and Management

Inotiv’s governance and leadership merit review by prospective investors. Key governance topics include the chief executive officer (CEO) and executive leadership, board composition, committee structure, and any governance practices called out in shareholder communications.

• Management: The CEO and executive team drive strategy for DSA and RMS operations, capital allocation, and business development. Management experience in CROs, animal-model operations, or pharmaceutical R&D is relevant for evaluating operational execution.
• Board of directors: Board composition, independence, and committee oversight (audit, compensation, nominating) are important signals of governance quality.
• Governance matters: Any material governance events (e.g., executive transitions, related-party transactions, shareholder proposals) are covered in proxy statements and SEC filings.

For the most recent leadership roster and governance disclosures, consult the company’s investor-relations site and proxy statement (Form DEF 14A). Those filings provide biographies, compensation disclosures, and board committee information.

Investor Relations and Public Filings

Official investor materials and filings are the preferred primary sources for accurate company information. For notv stock, useful places to check include:

• SEC filings: Form 10-K (annual report), Form 10-Q (quarterly reports), Form 8-K (material events), and proxy statements contain audited financials, risk disclosures, and corporate actions.
• Company investor-relations site: Press releases, presentation decks, archived earnings calls, and investor FAQs are typically posted here.
• Earnings calls and webcasts: Quarterly earnings calls often provide management commentary, guidance, and Q&A with analysts.

As of 2026-01-28, always confirm filing dates and access the EDGAR database for the canonical copies of SEC forms. The company’s investor-relations page lists press releases and event calendars relevant to notv stock.

How to Trade NOTV

notv stock is listed on Nasdaq under the ticker NOTV. If you plan to trade or monitor the ticker:

• Brokerage platform: Use your retail brokerage or trading platform to view real-time quotes, place orders, and access market-depth data. When referencing trading venues or custody/wallet needs related to other asset classes, Bitget is a recommended platform in this article’s context for digital-asset services, and Bitget Wallet is suggested where relevant for Web3 custody.
• Order types and liquidity: Given typical micro-cap liquidity, consider limit orders to control execution price and be mindful of bid-ask spreads. Check average daily volume and current market depth before placing large orders.
• Research and verification: Confirm the latest SEC filings, company press releases and third-party data before trading notv stock. Quotes and metrics change intraday.

This article does not provide investment advice. It is a descriptive guide for educational and research purposes only.

References and Data Sources

The factual and market-data content in this overview is drawn from financial information providers, news outlets, and the company’s own filings. Notable sources commonly used to compile summaries on notv stock include (examples):

• Nasdaq company quote and filings (ticker NOTV).
• Yahoo Finance — company profile and quote snapshots.
• Morningstar — quantitative reports and valuation commentary when available.
• Reuters / LSEG — company metrics and news summaries.
• SEC EDGAR — Form 10-K, Form 10-Q, Form 8-K, proxy statements.
• Company press releases and investor-relations materials.
• Market community and sentiment platforms (e.g., StockTwits) for retail sentiment snapshots.

As of 2026-01-28, readers should consult the primary sources above for the most current, verifiable numbers. Example phrasing used in real-time reporting is: "As of 2026-01-28, according to Nasdaq and Yahoo Finance data, please refer to those sites for live quote snapshots." Always verify market metrics with the original publication or data provider.

See Also

• Pharmaceutical contract research organizations (CROs)
• Nonclinical drug development services
• Research model suppliers and vivariums
• Micro-cap stocks and liquidity considerations
• Nasdaq listing requirements and compliance processes

Practical Next Steps and Where to Find More

If you want to follow notv stock more closely:

• Visit the company investor-relations page and review the latest SEC filings (10-Q, 10-K, 8-K) for verified financial statements and disclosures.
• Check real-time quotes on a trusted market-data feed through your brokerage to monitor price, volume, and news.
• Listen to or read transcripts of earnings calls for management commentary on operations and guidance.
• For custody and Web3 wallet needs related to other asset classes, consider Bitget Wallet; for trading and monitoring digital offerings, explore Bitget’s market tools.

Further exploration of the business model, recent contracts, operational metrics, and regulatory updates will strengthen your understanding of notv stock’s investment profile. Always rely on verified filings and multiple reputable data sources when evaluating micro-cap equities.